The promising and available effect of PDK1 in hyperglycemia-induced neuronal apoptosis and memory loss will identify the PDK1-lactic acid axis as a therapeutic target for the treatment of diabetic neuropathy. Here, PDK1 is linked to diabetic neuropathy.